Global Tuberculosis Testing Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026

MarketResearch.biz delivers in-depth insights on the global tuberculosis testing market in its upcoming report titled, “Global Tuberculosis Testing Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global tuberculosis testing market is estimated to register a CAGR of XXX% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global tuberculosis testing market report has been segmented on the basis of test type, end-user and region.

Tuberculosis (TB) is one of the leading infectious diseases in the world. Tuberculosis is caused by infection of the mycobacteria complex typically Mycobacterium tuberculosis (MTB). Other species such as M. africanum and M. bovis are also responsible for TB infection. Tuberculosis is transmitted from person to person by respiratory droplets. The bacteria usually attack the lungs, but can infect any part of the body such as the kidney, intestine, pleura, spine, and brain. Selection of the most suitable tests for detection of M. tuberculosis infection should be based on the context for testing, test availability, and overall cost effectiveness of testing. Early screening and targeted testing for tuberculosis (TB) is a key strategy for controlling and preventing infection. According to WHO, in 2015 an estimated 10.4 million people had tuberculosis, and 1.8 million people died.

Key driver of global tuberculosis testing market is increasing global prevalence of tuberculosis infection. In addition, growing geriatric population, growing focus on awareness programs by the governmental and NGO’s across the globe, availability of new improved tests for TB, are contributing to the global growth of this market. However, high cost of testing procedure and requirement of specialized equipment for testing may hinder growth of global tuberculosis testing market.

As the technology advances, new point-of-care tests for TB and drug-resistant TB tests will become available on the market and, with affordable prices of tests as well as physicians, patients, governments and global health agencies are looking for new ways to quickly and accurately identify active tuberculosis.

The market in Asia Pacific is expected to dominate market of the global tuberculosis testing market, due to increasing cases of tuberculosis. In countries such as China and India have the highest number of TB cases globally which is a major public health threat despite being a curable disease. According to WHO, in 2015, the largest number of new TB cases occurred in Asia-Pacific region with 61% of new cases, followed by Middle East & Africa, with 26% of new cases. The market in Middle East & Africa is expected to be emerging market of the global tuberculosis testing market, owing to increasing prevalence of tuberculosis. According to WHO, in 2016 about 2.5 million are suffering with TB in the African region, accounting for a quarter of new TB cases worldwide.

Global Tuberculosis Testing Market Segmentation:

Segmentation by test type:

• Nucleic acid testing (NAT)
• Mantoux test (TST)
• Smear microscopy
• IGRA (interferon-gamma release assays)
• Culture based tests
• Chest x-ray
• Xpert test
• Serological tests
• Others (including, drug susceptibility testing, adenosine deaminase (ADA) etc.)

Segmentation by end user:

• Hospital laboratories
• Research laboratories
• Clinics laboratories
• Diagnostic center
• Others (including, home health agencies etc.)

Segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• LIONEX Diagnostics & Therapeutics GmbH
• Thermo Fisher Scientific Inc.
• Hoffmann-La Roche Ltd.
• Hain Life science GmbH
• Creative Diagnostics
• Abbott Laboratories
• Becton, Dickinson and Company
• Epistem Holdings Plc.
• Alere Inc.
• Hologic Inc.